Edition:
India

Allogene Therapeutics Inc (ALLO.OQ)

ALLO.OQ on NASDAQ Stock Exchange Global Select Market

27.06USD
21 Aug 2019
Change (% chg)

-- (--)
Prev Close
$27.06
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
161,268
52-wk High
$35.55
52-wk Low
$21.67

About

Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on developing and commercializing of allogeneic T cell therapies for the treatment of cancer. It is involved in developing a pipeline of multiple allogeneic chimeric antigen receptor (CAR) T cell product candidates utilizing protein... (more)

Overall

No Ratios Available.

Financials

Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates